Robert J. van Ginkel

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol

Anke Kuijpers, B. Mirck, Arend G. J. Aalbers et al. · Annals of Surgical Oncology · 2013 · 233 citations · Full text

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study

Niels J. Harlaar, Marjory Koller, Steven J. de Jongh et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 177 citations · Full text

Surgical Oncology, Colorectal Surgery, Peritoneal Carcinomatosis +12

Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma

M. de Vries, W.G. Vonkeman, Robert J. van Ginkel et al. · European Journal of Surgical Oncology · 2006 · 159 citations

Surgical Oncology, Surgical Pathology, Melanoma +6

Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial

Charlotte E.L. Klaver, Gijsbert D. Musters, Willem A. Bemelman et al. · BMC Cancer · 2015 · 131 citations · Full text

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

Koen P. Rovers, Checca Bakkers, Geert A. Simkens et al. · BMC Cancer · 2019 · 108 citations · Full text